1057318-86-1 Usage
Description
2-(CarboxyMethylaMino)nicotinic Acid, also known as 2-(Carboxymethylamino) Nicotinic Acid, is an organic compound with the CAS number 1057318-86-1. It is characterized by its off-white solid appearance and is primarily used in the field of organic synthesis. 2-(CarboxyMethylaMino)nicotinic Acid holds potential for various applications due to its unique chemical properties.
Uses
Used in Organic Synthesis:
2-(CarboxyMethylaMino)nicotinic Acid is used as a synthetic building block for the creation of more complex organic molecules. Its unique structure allows it to be a valuable component in the synthesis of various compounds, contributing to the development of new materials and pharmaceuticals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-(CarboxyMethylaMino)nicotinic Acid is used as an intermediate in the development of new drugs. Its chemical properties make it a promising candidate for the synthesis of novel therapeutic agents, potentially leading to the discovery of innovative treatments for various medical conditions.
Used in Chemical Research:
2-(CarboxyMethylaMino)nicotinic Acid is also utilized in chemical research to study its properties and potential reactions with other compounds. This research can provide valuable insights into the compound's behavior and help identify new applications in various industries, including materials science and environmental science.
Check Digit Verification of cas no
The CAS Registry Mumber 1057318-86-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,7,3,1 and 8 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1057318-86:
(9*1)+(8*0)+(7*5)+(6*7)+(5*3)+(4*1)+(3*8)+(2*8)+(1*6)=151
151 % 10 = 1
So 1057318-86-1 is a valid CAS Registry Number.
1057318-86-1Relevant articles and documents
PYRROLOPYRIDINE CARBOXYLIC ACID DERIVATIVES
-
Page/Page column 95-96, (2010/04/03)
Disclosed are compounds and pharmaceutically acceptable salts of Formula (I) wherein R1, R2, R3, and RN are as defined herein. Compounds of Formula (I) are useful in the prevention and/or treatment of neurological and psychiatric disorder, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the disclosure and methods of treating the aforementioned conditions using such compounds.